HighMark Wealth Management »

Aptose Biosciences shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Aptose Biosciences (APTO) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Aptose Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aptose Biosciences held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptose Biosciences by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $498 300 1.66
2023-12-31 $762 300 2.54
2023-09-30 $840 300 2.80
2023-06-30 $1.4k 300 4.64

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Performant Finl (PFMT)
Eli Lilly & Co. (LLY)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Us Bancorp Del Com New (USB)
Paragon 28 (FNA)
Tela Bio (TELA)

View all positions for HighMark Wealth Management

Top funds holding Aptose Biosciences

DRW Holdings
Sigma Planning
Nantahala Capital Management
Citadel Advisors
Two Sigma Securities
Texas Capital Bank Wealth Management Services
PDS Planning
UBS Group
TD Waterhouse Canada
Royal Bank of Canada
Us Bancorp
Gleason Group
Newbridge Financial Services Group
Advisor Group Holdings
HighMark Wealth Management

View all funds holding Aptose Biosciences